IE
VTGN icon

Israel Englander’s VistaGen Therapeutics VTGN Stock Holding History

Israel Englander’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-430,404
Closed -$260K – 6452
2026
Q1 		$246K Buy
430,404
+233,359
+118% +$142K ﹤0.01% 5086
2025
Q4 		$130K Buy
197,045
+176,369
+853% +$637K ﹤0.01% 5582
2025
Q3 		$73.4K Buy
+20,676
New +$61.8K ﹤0.01% 5767
2025
Q1 		– Sell
-38,732
Closed -$114K – 6448
2024
Q4 		$114K Buy
38,732
+13,395
+53% +$37.7K ﹤0.01% 5453
2024
Q3 		$76.3K Buy
+25,337
New +$86.5K ﹤0.01% 5629
2024
Q2 		– Sell
-36,498
Closed -$193K – 6598
2024
Q1 		$193K Buy
+36,498
New +$175K ﹤0.01% 5391
2023
Q4 		– Sell
-16,870
Closed -$88.4K – 6595
2023
Q3 		$88.4K Sell
16,870
-84,200
-83% -$374K ﹤0.01% 5368
2023
Q2 		$189K Buy
+101,070
New +$354K ﹤0.01% 5138
2023
Q1 		– Sell
-3,583
Closed -$11K – 6909
2022
Q4 		$11K Sell
3,583
-24,904
-87% -$93.7K ﹤0.01% 6172
2022
Q3 		$130K Sell
28,487
-612
-2% -$6.07K ﹤0.01% 5866
2022
Q2 		$768K Sell
29,099
-12,244
-30% -$432K ﹤0.01% 4609
2022
Q1 		$1.54M Buy
41,343
+40,990
+11,612% +$1.79M ﹤0.01% 4109
2021
Q4 		$21K Sell
353
-14,492
-98% -$943K ﹤0.01% 6600
2021
Q3 		$1.22M Buy
14,845
+8,955
+152% +$778K ﹤0.01% 4464
2021
Q2 		$557K Sell
5,890
-40,656
-87% -$3.01M ﹤0.01% 5211
2021
Q1 		$2.97M Buy
46,546
+20,490
+79% +$1.37M ﹤0.01% 3143
2020
Q4 		$1.52M Buy
+26,056
New +$665K ﹤0.01% 3445
2019
Q1 		– Sell
-621
Closed -$28K – 4370
2018
Q4 		$28K Buy
+621
New +$33.8K ﹤0.01% 3653

Other funds holding VTGN

CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Israel Englander's VTGN Position: Q2 2026 in Review

Israel Englander sold out of VistaGen Therapeutics (VTGN) in Q2 2026, closing a stake of 430,404 shares — an estimated $260K sold.

Israel Englander first reported a position in VTGN in Q4 2018 and held it in 18 quarters. The position peaked at $2.97M in Q1 2021. 49 funds tracked by Wall St. Rank hold VTGN as of Q2 2026.

  • Israel Englander reported no remaining VistaGen Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 430,404 VistaGen Therapeutics shares in Q2 2026, an estimated $260K.
  • Israel Englander first reported a position in VistaGen Therapeutics in Q4 2018 and held it in 18 quarters.
  • Israel Englander's VistaGen Therapeutics position peaked at $2.97M in Q1 2021.
  • 49 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.